4.7 Article

MicroRNA-124 negatively regulates LPS-induced TNF-α production in mouse macrophages by decreasing protein stability

期刊

ACTA PHARMACOLOGICA SINICA
卷 37, 期 7, 页码 889-897

出版社

ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/aps.2016.16

关键词

microRNA-124; macrophages; LPS; TLR4; TNF-alpha; USP2; USP14

资金

  1. National Natural Science Foundation of China [81273606, 81473259, 81230083]
  2. National Science and Technology Major Project [2014ZX09J14103-08C]

向作者/读者索取更多资源

Aim: MicroRNAs play pivotal roles in regulation of both innate and adaptive immune responses. In the present study, we investigated the effects of microRNA-124 (miR-124) on production of the pro-inflammatory cytokine TNF-alpha in lipopolysaccharide (LPS)-treated mouse macrophages. Methods: Mouse macrophage cell line RAW264.7 was stimulated with LPS (100 ng/mL). The levels of miR-124 and TNF-alpha mRNA were evaluated using q-PCR. ELISA and Western blotting were used to detect TNF-alpha protein level in cell supernatants and cells, respectively. 3'-UTR luciferase reporter assays were used to analyze the targets of miR-124. For in vivo experiments, mice were injected with LPS (30 mg/kg, ip). Results: LPS stimulation significantly increased the mRNA level of miR-124 in RAW264.7 macrophages in vitro and mice in vivo. In RAW264.7 macrophages, knockdown of miR-124 with miR-124 inhibitor dose-dependently increased LPS-stimulated production of TNF-alpha protein and prolonged the half-life of TNF-alpha protein, but did not change TNF-alpha mRNA levels, whereas overexpression of miR-124 with miR-124 mimic produced the opposite effects. Furthermore, miR-124 was found to directly target two components of deubiquitinating enzymes: ubiquitin-specific proteases (USP) 2 and 14. Knockdown of USP2 or USP14 accelerated protein degradation of TNF-alpha, and abolished the effect of miR-124 on TNF-alpha protein stability. Conclusion: miR-124, targeting USP2 and USP14, negatively regulates LPS-induced TNF-alpha production in mouse macrophages, suggesting miR-124 as a new therapeutic target in inflammation-related diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据